Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"TFCP2"”.

  1. Structural Basis of Gene Regulation by the Transcription Factors Tfcp2l1 and Tfcp2

    Mammalian Tfcp2l1 and Tfcp2 are grouped into the CP2 subfamily of the grainyhead/CP2 (Grh/CP2) transcription factors involved in pluripotency maintenance and self-renewal of embryonic stem cells. In addition, Tfcp2l1 has been implicated in a variety of cancers such as breast cancer, thyroid cancer, …

    fu-berlin Repository record for Structural Basis of Gene Regulation by the Transcription Factors Tfcp2l1 and Tfcp2 (opens in a new tab)

  2. Preclinical assessment of dihydroquinolinone inhibitors directly targeting oncogene TFCP2 as cancer therapeutics

    The transcription factor TFCP2 is a pro-oncogenic factor in hepatocellular carcinoma, colorectal cancer, pancreatic cancer, breast cancer, glioma, rhabdomyosarcoma, squamous cell sarcoma, cervical cancer and ovarian cancer. TFCP2 promotes cell proliferation, invasion, angiogenesis, stemness and …

    bu Repository record for Preclinical assessment of dihydroquinolinone inhibitors directly targeting oncogene TFCP2 as cancer therapeutics (opens in a new tab)

  3. Χειρουργική αντιμετώπιση και θεραπεία του ραβδομυοσαρκώματος: Νεότερα δεδομένα για την πρόγνωση και θεραπεία του

    … νέους υποτύπους, όπως το ενδοοστικό RMS με TFCP2/NCOA2 συντήξεις και το RMS που προκύπτει από φλεγμονώδη ραβδομυοβλαστικό όγκο, αναδεικνύοντας την εξελισσόμενη πολυπλοκότητα διάγνωσης του RMS. Η πρόγνωση των ασθενών με RMS επηρεάζεται από μια σειρά παραγόντων, όπως είναι η ηλικία του …

    athens Repository record for Χειρουργική αντιμετώπιση και θεραπεία του ραβδομυοσαρκώματος: Νεότερα δεδομένα για την πρόγνωση και θεραπεία του (opens in a new tab)

  4. Transcription factor LSF: a mitotic regulator in hepatocellular carcinoma cells

    Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. Current treatments are subpar, with late stage diagnosis and poor prognosis contributing to limited treatment options. The evolutionarily conserved, ubiquitously expressed transcription factor LSF is …

    bu Repository record for Transcription factor LSF: a mitotic regulator in hepatocellular carcinoma cells (opens in a new tab)